Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). It induces cell apoptosis of cancer cells and inhibits tumor growth and can be used for the research of cancer. MW :150 KD.

• Supplier: Selleck Chemicals
• Product #: A2604
• Sku #: A2604-1mg